<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou D</submitter><funding>Natural Science Foundation of Zhejiang Province</funding><funding>National Natural Science Foundation of China</funding><funding>Shanghai Municipal Health Bureau</funding><pagination>110904</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12702014</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>301(12)</volume><pubmed_abstract>Growing evidence indicates that the cellular senescence (CS) plays a crucial role in hepatocarcinogenesis. Transmembrane BCL-2-associated X protein inhibitor motif containing 1 (TMBIM1) has been shown to inhibit CS. However, the role and mechanism of TMBIM1 associated CS in hepatocarcinogenesis remains unclear. In our study, TMBIM1 was highly expressed in the adjacent tissues of patients with liver cancer and its expression of TMBIM1 gradually decreased during hepatocarcinogenesis in a rat primary liver cancer model. In a Tmbim1-overexpressed rat model, the occurrence of hepatocellular carcinoma (HCC) was highly inhibited and overall survival was prolonged. In addition, the aggregation of senescent cells promotes the activation of hepatic progenitor cells to promote the occurrence of HCC. </pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Transmembrane BAX inhibitor motif containing 1 inhibition of lysosomal degradation of TGF-β receptor 1 suppresses cellular senescence and hepatocarcinogenesis.</pubmed_title><pmcid>PMC12702014</pmcid><funding_grant_id>82073037</funding_grant_id><funding_grant_id>82203237</funding_grant_id><funding_grant_id>20214Y0013</funding_grant_id><funding_grant_id>LQ23H160049</funding_grant_id><funding_grant_id>82472997</funding_grant_id><funding_grant_id>82173276</funding_grant_id><funding_grant_id>82073032</funding_grant_id><funding_grant_id>82472928</funding_grant_id><funding_grant_id>82302915</funding_grant_id><funding_grant_id>2024ZZ2006</funding_grant_id><pubmed_authors>Jiang J</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Duan L</pubmed_authors><pubmed_authors>Zhang K</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Hou X</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Qian X</pubmed_authors><pubmed_authors>Zhou D</pubmed_authors><pubmed_authors>Yu W</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Xue M</pubmed_authors><pubmed_authors>Feng S</pubmed_authors><pubmed_authors>Wei L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transmembrane BAX inhibitor motif containing 1 inhibition of lysosomal degradation of TGF-β receptor 1 suppresses cellular senescence and hepatocarcinogenesis.</name><description>Growing evidence indicates that the cellular senescence (CS) plays a crucial role in hepatocarcinogenesis. Transmembrane BCL-2-associated X protein inhibitor motif containing 1 (TMBIM1) has been shown to inhibit CS. However, the role and mechanism of TMBIM1 associated CS in hepatocarcinogenesis remains unclear. In our study, TMBIM1 was highly expressed in the adjacent tissues of patients with liver cancer and its expression of TMBIM1 gradually decreased during hepatocarcinogenesis in a rat primary liver cancer model. In a Tmbim1-overexpressed rat model, the occurrence of hepatocellular carcinoma (HCC) was highly inhibited and overall survival was prolonged. In addition, the aggregation of senescent cells promotes the activation of hepatic progenitor cells to promote the occurrence of HCC. </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-15T11:17:10.353Z</modification><creation>2026-07-04T03:12:02.161Z</creation></dates><accession>S-EPMC12702014</accession><cross_references><pubmed>41197720</pubmed><doi>10.1016/j.jbc.2025.110904</doi></cross_references></HashMap>